Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

CDKL5 harbours loss of function mutations causing a variant of #RettSyndrome, & may be a drug target for acute kidney injury. Our #CDKL5 Target Enabling Package (#TEP) shows structures (with inhibitors), in vitro assays, & functional analyses in C. elegans